P

Inventor

ZEITLIN ANDREW L

US18 patents
⚠️ This page may combine multiple inventors who share the name “ZEITLIN ANDREW L”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

CELGENE CORP

17 patents
US5908850AJun 1, 1999

Method of treating attention deficit disorders with d-threo methylphenidate

CELGENE CORP211 citations99
US6528530B2Mar 4, 2003

Phenidate drug formulations having diminished abuse potential

CELGENE CORP132 citations98
US6355656B1Mar 12, 2002

Phenidate drug formulations having diminished abuse potential

CELGENE CORP147 citations98
US6635284B2Oct 21, 2003

Delivery of multiple doses of medications

CELGENE CORP102 citations97
US5300437AApr 5, 1994

Enantiomeric enrichment and stereoselective synthesis of chiral amines

CELGENE CORP120 citations97
US7431944B2Oct 7, 2008

Delivery of multiple doses of medications

CELGENE CORP49 citations96
US6255325B1Jul 3, 2001

Chronic, bolus administration of D-threo methylphenidate

CELGENE CORP53 citations96
US4950606AAug 21, 1990

Enantiomeric enrichment and stereoselective synthesis of chiral amines

CELGENE CORP89 citations96
US5346828ASep 13, 1994

Stereoisomeric enrichment of 2-amino-3-hydroxy-3-phenylpropionic acids using d-threonine aldolase

CELGENE CORP55 citations95
US5169780ADec 8, 1992

Enantiomeric enrichment and stereoselective synthesis of chiral amines

CELGENE CORP89 citations93
US6602887B2Aug 5, 2003

Chronic, bolus administration of D-threo methylphenidate

CELGENE CORP28 citations92
US6486177B2Nov 26, 2002

Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidate

CELGENE CORP31 citations92
US5922736AJul 13, 1999

Chronic, bolus administration of D-threo methylphenidate

CELGENE CORP34 citations92
US5733756AMar 31, 1998

Lactams and processes for stereoselective enrichment of lactams, amides, and esters

CELGENE CORP46 citations92
US7115631B2Oct 3, 2006

Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidate

CELGENE CORP39 citations90
US7435726B2Oct 14, 2008

Compositions and methods for the treatment of cancer

CELGENE CORP14 citations79
US5985933ANov 16, 1999

Methods for treating central and peripheral nerve pain

CELGENE CORP15 citations74

(unassigned)

1 patent